Clinical Features and Outcomes of Adrenal Cavernous Hemangioma: A Study of 8 Cases from a Single Center

Background. Cavernous hemangioma is a rare benign tumor that develops from the adrenal glands. In this study, we present our experience with patients with adrenal cavernous hemangiomas (ACH) in a Chinese population. Methods. Demographic, diagnostic, surgical, and pathological findings in patients at...

Full description

Saved in:
Bibliographic Details
Main Authors: Henghai Huang, Xiaoyun Wu, Xiaocao Lin, Delin Li, Jingjing Zeng
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2021/5549925
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550594068348928
author Henghai Huang
Xiaoyun Wu
Xiaocao Lin
Delin Li
Jingjing Zeng
author_facet Henghai Huang
Xiaoyun Wu
Xiaocao Lin
Delin Li
Jingjing Zeng
author_sort Henghai Huang
collection DOAJ
description Background. Cavernous hemangioma is a rare benign tumor that develops from the adrenal glands. In this study, we present our experience with patients with adrenal cavernous hemangiomas (ACH) in a Chinese population. Methods. Demographic, diagnostic, surgical, and pathological findings in patients at a single institution who were adrenalectomized as a result of ACH were retrospectively reviewed. Results. Among 601 patients who underwent adrenalectomy, 8 (1.33%; 5 men, 3 women) cases were diagnosed with ACH between January 1, 1998, and December 31, 2018, in a single institution. The mean age was 53.25 ± 11.9 years (range, 35–67 years). Four (50%) were asymptomatic, and three (37.5%) complained of abdominal or flank discomfort. Preoperative computed tomography (CT) revealed ACH in 3 (37.5%) cases. Well-defined borders and heterogeneous enhancement with characteristic progressive partial filling-in were characteristic CT features of ACH (tumor size>3 cm). The mean tumor size was 5.16 ± 3.4 cm (range, 1.5–11 cm). No recurrence occurred during a median follow-up period of 38.37 months (range, 8–60 months). Conclusions. ACH was asymptomatic in most cases, and diagnosis could be challenging. Adrenalectomy is a safe treatment modality for ACH, and it ensures favorable outcomes.
format Article
id doaj-art-e31ccf60b6d440b0ac2ae851018dda8b
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-e31ccf60b6d440b0ac2ae851018dda8b2025-02-03T06:06:28ZengWileyInternational Journal of Endocrinology1687-83371687-83452021-01-01202110.1155/2021/55499255549925Clinical Features and Outcomes of Adrenal Cavernous Hemangioma: A Study of 8 Cases from a Single CenterHenghai Huang0Xiaoyun Wu1Xiaocao Lin2Delin Li3Jingjing Zeng4Department of Urology, Wuzhou GongRen Hospital, Wuzhou, GuangXi, ChinaDepartment of Nursing, GuangXi Medical College, Nanning, GuangXi, ChinaDepartment of Urology, Wuzhou GongRen Hospital, Wuzhou, GuangXi, ChinaDepartment of Urology, Wuzhou GongRen Hospital, Wuzhou, GuangXi, ChinaDepartment of Pathology, The First Affliated Hospital of GuangXi Medical University, Nanning, GuangXi, ChinaBackground. Cavernous hemangioma is a rare benign tumor that develops from the adrenal glands. In this study, we present our experience with patients with adrenal cavernous hemangiomas (ACH) in a Chinese population. Methods. Demographic, diagnostic, surgical, and pathological findings in patients at a single institution who were adrenalectomized as a result of ACH were retrospectively reviewed. Results. Among 601 patients who underwent adrenalectomy, 8 (1.33%; 5 men, 3 women) cases were diagnosed with ACH between January 1, 1998, and December 31, 2018, in a single institution. The mean age was 53.25 ± 11.9 years (range, 35–67 years). Four (50%) were asymptomatic, and three (37.5%) complained of abdominal or flank discomfort. Preoperative computed tomography (CT) revealed ACH in 3 (37.5%) cases. Well-defined borders and heterogeneous enhancement with characteristic progressive partial filling-in were characteristic CT features of ACH (tumor size>3 cm). The mean tumor size was 5.16 ± 3.4 cm (range, 1.5–11 cm). No recurrence occurred during a median follow-up period of 38.37 months (range, 8–60 months). Conclusions. ACH was asymptomatic in most cases, and diagnosis could be challenging. Adrenalectomy is a safe treatment modality for ACH, and it ensures favorable outcomes.http://dx.doi.org/10.1155/2021/5549925
spellingShingle Henghai Huang
Xiaoyun Wu
Xiaocao Lin
Delin Li
Jingjing Zeng
Clinical Features and Outcomes of Adrenal Cavernous Hemangioma: A Study of 8 Cases from a Single Center
International Journal of Endocrinology
title Clinical Features and Outcomes of Adrenal Cavernous Hemangioma: A Study of 8 Cases from a Single Center
title_full Clinical Features and Outcomes of Adrenal Cavernous Hemangioma: A Study of 8 Cases from a Single Center
title_fullStr Clinical Features and Outcomes of Adrenal Cavernous Hemangioma: A Study of 8 Cases from a Single Center
title_full_unstemmed Clinical Features and Outcomes of Adrenal Cavernous Hemangioma: A Study of 8 Cases from a Single Center
title_short Clinical Features and Outcomes of Adrenal Cavernous Hemangioma: A Study of 8 Cases from a Single Center
title_sort clinical features and outcomes of adrenal cavernous hemangioma a study of 8 cases from a single center
url http://dx.doi.org/10.1155/2021/5549925
work_keys_str_mv AT henghaihuang clinicalfeaturesandoutcomesofadrenalcavernoushemangiomaastudyof8casesfromasinglecenter
AT xiaoyunwu clinicalfeaturesandoutcomesofadrenalcavernoushemangiomaastudyof8casesfromasinglecenter
AT xiaocaolin clinicalfeaturesandoutcomesofadrenalcavernoushemangiomaastudyof8casesfromasinglecenter
AT delinli clinicalfeaturesandoutcomesofadrenalcavernoushemangiomaastudyof8casesfromasinglecenter
AT jingjingzeng clinicalfeaturesandoutcomesofadrenalcavernoushemangiomaastudyof8casesfromasinglecenter